Dr. Κατσόγιαννος Πέτρος MD, PhD

Σπουδές

• Διδάκτωρ, Ιατρική Σχολή, Uppsala University, Σουηδία (2014 - 2020)
• Πτυχίο Ιατρικής, Ιατρική Σχολή, Semmelweis University, Ουγγαρία (1997 - 2003)
• Ειδικότητα Ενδοκρινολογίας - Διαβητολογίας, Uppsala University Hospital, Σουηδία (2012 - 2015)
• Ειδικότητα Παθολογίας, Uppsala University Hospital, Σουηδία (2007 - 2012)

Επαγγελματική εμπειρία

• Ιδιωτικό ιατρείο, Παλλήνη (2022 - σήμερα)
• Επιμελητής Α' Ενδοκρινολόγος - Διαβητολόγος, Linköping University Hospital, Σουηδία (2023 - σήμερα)
• Συνεργάτης, Νοσοκομείο "Υγεία" (2023 - σήμερα)
• Επιστημονικά Υπεύθυνος, Διαγνωστικά Κέντρα "Affidea", Περιστέρι & Αθήνα (2022 - σήμερα)
• Επιμελητής Α' Ενδοκρινολόγος - Διαβητολόγος, Uppsala University Hospital, Σουηδία (2020 - 2023)
• Επιμελητής Β' Ενδοκρινολόγος - Διαβητολόγος, Uppsala University Hospital, Σουηδία (2015 - 2020)
• Συνεργάτης, Θεραπευτήριο Αθηνών
• Διδάσκων, Ιατρική Σχολή, Uppsala University, Σουηδία
• Υπηρεσία υπαίθρου, Γενικό Νοσοκομείο Βόλου "Αχιλλοπούλειο", Κέντρο Υγείας Αργαλαστής & Περιφερειακό Ιατρείο Μηλεών (2004 - 2006)
• περισσότερα

Μέλος συλλόγων

• Ελληνική Ενδοκρινολογική Εταιρεία
• Swedish Endocrine Society (SES)

Δημοσιεύσεις

• Randell, Eva & Katsogiannos, Petros & Rn, Janeth & Eriksson, Jan & Magnus, Sundbom & Engström, Maria. (2023). Complementary elements of support after gastric-bypass surgery perceived by adults with previous type 2 diabetes: A qualitative study 2 years after bariatric surgery. Clinical Obesity. 13. 10.1111/cob.12610. (2023)
• Fanni, Giovanni & Katsogiannos, Petros & Nandi Jui, Bipasha & Magnus, Sundbom & Hetty, Susanne & Pereira, Maria & Eriksson, Jan & Eriksson, Jan. (2022). Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass. Endocrine Connections. 11. (2022)
• Almby, Kristina & Katsogiannos, Petros & Pereira, Maria & Karlsson, F & Magnus, Sundbom & Wiklund, Urban & Kamble, Prasad & Eriksson, Jan. (2021). Time course of metabolic, neuroendocrine and adipose effects during 2 years of follow-up after RYGB in patients with T2D. The Journal of Clinical Endocrinology & Metabolism. 106. 10.1210/clinem/dgab398. (2021)
• Eriksson, Jan & Visvanathar, Robin & Kullberg, Joel & Strand, Robin & Skrtic, Stanko & Ekström, Simon & Lubberink, Mark & Lundqvist, Martin & Katsogiannos, Petros & Pereira, Maria & Ahlström, Håkan. (2021). Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes: Whole-body PET/MRI during hyperinsulinemia. European Journal of Endocrinology. 184. 10.1530/EJE-20-1359. (2021)
• Katsogiannos, Petros & Kamble, Prasad & Pereira, Maria & Magnus, Sundbom & Carlsson, Per‐Ola & Eriksson, Jan & Espes, Daniel. (2021). Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes. Obesity. 29. 535-542. 10.1002/oby.23093. (2021)
• Katsogiannos, Petros & Randell, Eva & Magnus, Sundbom & Rosenblad, Andreas & Eriksson, Jan & Rn, Janeth. (2020). Quality of life after gastric bypass surgery in patients with type 2 diabetes: Patients' experiences during 2 years of follow-up. Diabetology & Metabolic Syndrome. 12. 90. 10.1186/s13098-020-00597-1. (2020)
• Ahmed, Fozia & Sarsenbayeva, Assel & Katsogiannos, Petros & Aguer, Céline & Pereira, Maria. (2020). The effects of bisphenol A and bisphenol S on adipokine expression and glucose metabolism in human adipose tissue. Toxicology. 445. 152600. 10.1016/j.tox.2020.152600. (2020)
• Sjöholm, Åke & Pereira, Maria & Nilsson, Thomas & Linde, Torbjörn & Katsogiannos, Petros & Saaf, Jan & Eriksson, Jan. (2020). Type B insulin resistance syndrome. Lakartidningen. 117. (2020)
• Sjöholm, Åke & Pereira, Maria & Nilsson, Thomas & Linde, Torbjörn & Katsogiannos, Petros & Saaf, Jan & Eriksson, Jan. (2020). Type B insulin resistance syndrome in a patient with type 1 diabetes. Endocrinology, Diabetes & Metabolism Case Reports. 2020. 10.1530/EDM-19-0157. (2020)
• Katsogiannos, Petros & Kamble, Prasad & Wiklund, Urban & Magnus, Sundbom & Espes, Daniel & Hammar, Ulf & Karlsson, F. & Pereira, Maria & Eriksson, Jan. (2020). Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery. Endocrine. 67. 10.1007/s12020-020-02203-w. (2020)
• Katsogiannos, Petros & Kamble, Prasad & Boersma, Gretha & Karlsson, F & Lundkvist, Per & Magnus, Sundbom & Pereira, Maria & Eriksson, Jan. (2019). Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D. The Journal of Clinical Endocrinology & Metabolism. 104. 10.1210/jc.2018-02165. (2019)
• Sidibeh, Cherno & Pereira, Maria & Abalo, Xesús & Boersma, Gretha & Skrtic, Stanko & Lundkvist, Per & Katsogiannos, Petros & Hausch, Felix & Castillejo-López, Casimiro & Eriksson, Jan. (2018). FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes. Endocrine. 62. 1-13. 10.1007/s12020-018-1674-5. (2018)
• Lundkvist, Per & Pereira, Maria & Kamble, Prasad & Katsogiannos, Petros & Langkilde, Anna & Esterline, Russell & Johnsson, Eva & Eriksson, Jan. (2018). Glucagon Levels during Short-term SGLT2 Inhibition are Largely Regulated by Glucose Changes in Type 2 Diabetes Patients. The Journal of Clinical Endocrinology & Metabolism. 104. 10.1210/jc.2018-00969. (2018)
• Boersma, Gretha & Johansson, Emil & Pereira, Maria & Heurling, Kerstin & Skrtic, Stanko & Lau, Joey & Katsogiannos, Petros & Panagiotou, Grigorios & Lubberink, Mark & Kullberg, Joel & Ahlström, Håkan & Eriksson, Jan. (2018). Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study. Hormone and Metabolic Research. 50. e10-e10. 10.1055/a-0831-3620. (2018)
• Boersma, Gretha & Johansson, Emil & Pereira, Maria & Heurling, Kerstin & Skrtic, Stanko & Lau, Joey & Katsogiannos, Petros & Panagiotou, Grigorios & Lubberink, Mark & Kullberg, Joel & Ahlström, Håkan & Eriksson, Jan. (2018). Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study. Hormone and Metabolic Research. 50. 10.1055/a-0643-4739. (2018)
• Boersma, Gretha & Heurling, Kerstin & Pereira, Maria & Johansson, Emil & Lubberink, Mark & Katsogiannos, Petros & Skrtic, Stanko & Kullberg, Joel & Ahlström, Håkan & Eriksson, Jan. (2018). Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Strongly Predict Whole-Body Insulin Resistance in the Development of Type 2 Diabetes. Diabetes. 67. 1790-P. 10.2337/db18-1790-P. (2018)
• Katsogiannos, Petros & Boersma, Gretha & Kamble, Prasad & Pereira, Maria & Lundkvist, Per & Karlsson, Anders & Magnus, Sundbom & Eriksson, Jan. (2018). Early Changes in Glucose Homeostasis after Gastric Bypass Surgery in Patients with T2DM—Role of Adipose Tissue Mechanisms?. Diabetes. 67. 1756-P. 10.2337/db18-1756-P. (2018)
• Eriksson, JW & Lundkvist, P & Sjöström, D & Katsogiannos, Petros & Pereira, MJ & Johnsson, E & Stürzenhofecker, B. (2017). Einjährige Behandlung adipöser Erwachsenen ohne Diabetes mit einer Kombination von Dapagliflozin und wöchentlichem Exenatide: Ergebnisse einer offenen Verlängerungsstudie. Diabetologie und Stoffwechsel. 12. 10.1055/s-0037-1601676. (2017)
• Lundkvist, Per & Pereira, Maria & Katsogiannos, Petros & Sjostrom, David & Johnsson, Eva & Eriksson, Jan. (2017). Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1year. Diabetes, obesity & metabolism. 19. 10.1111/dom.12954. (2017)
• Sidibeh, Cherno & Pereira, Maria & Lau, Joey & Kamble, Prasad & Skrtic, Stanko & Katsogiannos, Petros & Magnus, Sundbom & Svensson, Maria & Eriksson, Jan. (2017). Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance. Endocrine. 55. 10.1007/s12020-016-1172-6. (2017)
• περισσότερα